These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 10392668)
41. The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review. Weberschock T; Meister AC; Bohrt K; Schmitt J; Boehncke WH; Ludwig RJ Contact Dermatitis; 2011 Oct; 65(4):187-94. PubMed ID: 21631519 [TBL] [Abstract][Full Text] [Related]
42. High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy. Schindewolf M; Gobst C; Kroll H; Recke A; Louwen F; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ J Allergy Clin Immunol; 2013 Jul; 132(1):131-9. PubMed ID: 23726261 [TBL] [Abstract][Full Text] [Related]
43. Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice. Solak B Am J Ther; 2016; 23(6):e1911-e1917. PubMed ID: 25853237 [TBL] [Abstract][Full Text] [Related]
44. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update. Jappe U Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645 [TBL] [Abstract][Full Text] [Related]
45. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846 [TBL] [Abstract][Full Text] [Related]
46. Differential diagnosis of late-type reactions to injected local anaesthetics: Inflammation at the injection site is the only indicator of allergic hypersensitivity. Trautmann A; Stoevesandt J Contact Dermatitis; 2019 Feb; 80(2):118-124. PubMed ID: 30311217 [TBL] [Abstract][Full Text] [Related]
47. Necrotizing skin lesions induced by low-molecular-weight heparin after total knee arthroplasty. Plath J; Schulze R; Barz D; Krammer B; Steiner M; Anders O; Mach J Arch Orthop Trauma Surg; 1997; 116(6-7):443-5. PubMed ID: 9266063 [TBL] [Abstract][Full Text] [Related]
58. Delayed-type hypersensitivity to subcutaneous enoxaparin. Méndez J; Sanchís ME; de la Fuente R; Stolle R; Vega JM; Martínez C; Armentia A; Sánchez P; Fernández A Allergy; 1998 Oct; 53(10):999-1003. PubMed ID: 9821483 [TBL] [Abstract][Full Text] [Related]
59. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229 [TBL] [Abstract][Full Text] [Related]
60. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies. Tonn ME; Schaiff RA; Kollef MH Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]